• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中 Aβ 的错误折叠与体重指数呈负相关,即使在中年也是如此。

Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood.

机构信息

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Im Neuenheimer Feld 581, Heidelberg, Germany.

Network Aging Research, Heidelberg University, Bergheimer Straße 20, Heidelberg, Germany.

出版信息

Alzheimers Res Ther. 2021 Aug 30;13(1):145. doi: 10.1186/s13195-021-00889-2.

DOI:10.1186/s13195-021-00889-2
PMID:34461995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8406782/
Abstract

BACKGROUND

To understand the potential for early intervention and prevention measures in Alzheimer's disease, the association between risk factors and early pathological change needs to be assessed. Hence, the aim of this study was to determine whether risk factors of Alzheimer's clinical syndrome (clinical AD), such as body mass index (BMI), are associated with Aβ misfolding in blood, a strong risk marker for AD among older adults.

METHODS

Information on risk factors and blood samples were collected at baseline in the ESTHER study, a population-based cohort study of older adults (age 50-75 years) in Germany. Aβ misfolding in blood plasma was analyzed using an immuno-infrared-sensor in a total of 872 participants in a nested case-control design among incident dementia cases and matched controls. Associations between risk factors and Aβ misfolding were assessed by multiple logistic regression. For comparison, the association between the risk factors and AD incidence during 17 years of follow-up was investigated in parallel among 5987 cohort participants.

RESULTS

An inverse association with Aβ misfolding was seen for BMI at age 50 based on reported weight history (aOR 0.64, 95% CI 0.43-0.96, p = 0.03). Similar but not statistically significant associations were seen for BMI at baseline (i.e., mean age 68) and at age 40. No statistically significant associations with Aβ misfolding were found for other risk factors, such as diabetes, smoking, and physical activity. On the other hand, low physical activity was associated with a significantly reduced risk of developing clinical AD compared to physical inactivity.

CONCLUSIONS

Our results support that AD pathology may be detectable and associated with reduced weight even in middle adulthood, many years before clinical diagnosis of AD. Physical activity might reduce the risk of onset of AD symptoms.

摘要

背景

为了了解阿尔茨海默病早期干预和预防措施的潜力,需要评估风险因素与早期病理变化之间的关系。因此,本研究旨在确定阿尔茨海默病临床综合征(临床 AD)的风险因素,如体重指数(BMI),是否与老年人群中 AD 的强烈风险标志物——血液中的 Aβ 错误折叠有关。

方法

在德国一项基于人群的老年(50-75 岁)队列研究 ESTHER 中,在基线时收集了风险因素和血液样本信息。在一项嵌套病例对照设计中,使用免疫红外传感器分析了共 872 名新发痴呆病例和匹配对照者的血液血浆 Aβ 错误折叠情况。使用多因素逻辑回归评估风险因素与 Aβ 错误折叠之间的关系。为了进行比较,还在 5987 名队列参与者中平行研究了这些风险因素与 17 年随访期间 AD 发生率之间的关系。

结果

基于报告的体重史,发现 50 岁时 BMI 与 Aβ 错误折叠呈负相关(优势比 0.64,95%置信区间 0.43-0.96,p=0.03)。在基线(即平均年龄 68 岁)和 40 岁时也观察到类似但无统计学意义的关联。其他风险因素,如糖尿病、吸烟和身体活动,与 Aβ 错误折叠之间没有统计学上的显著关联。另一方面,与不活动相比,低身体活动与显著降低发生临床 AD 的风险相关。

结论

我们的研究结果支持 AD 病理学可能在中年时期,甚至在临床诊断 AD 多年前就可以被检测到,并与体重减轻有关。身体活动可能会降低 AD 症状发作的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/8406782/7cbf870f1d13/13195_2021_889_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/8406782/c81feb78fb9b/13195_2021_889_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/8406782/7cbf870f1d13/13195_2021_889_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/8406782/c81feb78fb9b/13195_2021_889_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/8406782/7cbf870f1d13/13195_2021_889_Fig2_HTML.jpg

相似文献

1
Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood.血浆中 Aβ 的错误折叠与体重指数呈负相关,即使在中年也是如此。
Alzheimers Res Ther. 2021 Aug 30;13(1):145. doi: 10.1186/s13195-021-00889-2.
2
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.淀粉样蛋白-β错误折叠作为一种血浆生物标志物,可提示有主观认知下降的个体未来发生临床阿尔茨海默病的风险。
Alzheimers Res Ther. 2020 Dec 24;12(1):169. doi: 10.1186/s13195-020-00738-8.
3
Aβ misfolding in blood plasma measured by immuno-infrared-sensor as an age-independent risk marker of Alzheimer's disease.通过免疫红外传感器测量血浆中β淀粉样蛋白错误折叠作为阿尔茨海默病与年龄无关的风险标志物。
Alzheimers Dement (Amst). 2021 Feb 10;13(1):e12151. doi: 10.1002/dad2.12151. eCollection 2021.
4
Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors.通过血浆中 Aβ 错误折叠与 APOE4 状态和其他风险因素比较,预测 14 年内的阿尔茨海默病诊断。
Alzheimers Dement. 2020 Feb;16(2):283-291. doi: 10.1016/j.jalz.2019.08.189. Epub 2020 Jan 6.
5
Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease.遗传易感性、血浆中的 Aβ 错误折叠与阿尔茨海默病。
Transl Psychiatry. 2021 May 1;11(1):261. doi: 10.1038/s41398-021-01380-0.
6
Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.性别特异性终生体重指数与阿尔茨海默病神经影像学生物标志物的关联。
J Alzheimers Dis. 2020;75(3):767-777. doi: 10.3233/JAD-191216.
7
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.血浆β淀粉样蛋白与老年男性患阿尔茨海默病和痴呆症的风险:一项基于人群的前瞻性队列研究。
Arch Neurol. 2008 Feb;65(2):256-63. doi: 10.1001/archneurol.2007.57.
8
Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.评估无痴呆症的老年个体血浆 Aβ 作为阿尔茨海默病的预测因子:一项基于人群的研究。
J Alzheimers Dis. 2012;28(1):231-8. doi: 10.3233/JAD-2011-111418.
9
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.淀粉样β沉积、神经退行性变与散发性阿尔茨海默病认知衰退:一项前瞻性队列研究。
Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.
10
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.痛风与阿尔茨海默病风险:一项基于人群的、体重指数匹配的队列研究。
Ann Rheum Dis. 2016 Mar;75(3):547-51. doi: 10.1136/annrheumdis-2014-206917. Epub 2015 Mar 4.

引用本文的文献

1
Independent effect of body mass index variation on amyloid-β positivity.体重指数变化对β淀粉样蛋白阳性的独立影响。
Front Aging Neurosci. 2022 Jul 22;14:924550. doi: 10.3389/fnagi.2022.924550. eCollection 2022.

本文引用的文献

1
Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.更正:在一个基于社区的队列中,通过多基因风险评分和APOE状态对阿尔茨海默病、血管性痴呆、混合性痴呆和全因性痴呆的临床诊断进行预测,该队列进行了长达17年的前瞻性随访。
Mol Psychiatry. 2021 Oct;26(10):5823. doi: 10.1038/s41380-021-01311-x.
2
Aβ misfolding in blood plasma measured by immuno-infrared-sensor as an age-independent risk marker of Alzheimer's disease.通过免疫红外传感器测量血浆中β淀粉样蛋白错误折叠作为阿尔茨海默病与年龄无关的风险标志物。
Alzheimers Dement (Amst). 2021 Feb 10;13(1):e12151. doi: 10.1002/dad2.12151. eCollection 2021.
3
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
淀粉样蛋白-β错误折叠作为一种血浆生物标志物,可提示有主观认知下降的个体未来发生临床阿尔茨海默病的风险。
Alzheimers Res Ther. 2020 Dec 24;12(1):169. doi: 10.1186/s13195-020-00738-8.
4
Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.淀粉样β负担预测临床正常成年人的体重指数(BMI)呈前瞻性下降。
Neurobiol Aging. 2020 Sep;93:124-130. doi: 10.1016/j.neurobiolaging.2020.03.002. Epub 2020 Mar 7.
5
The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.年龄和肥胖对血小板淀粉样前体蛋白加工以及氧化应激和炎症的血浆标志物的影响。
Exp Gerontol. 2020 Apr;132:110838. doi: 10.1016/j.exger.2020.110838. Epub 2020 Jan 22.
6
Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors.通过血浆中 Aβ 错误折叠与 APOE4 状态和其他风险因素比较,预测 14 年内的阿尔茨海默病诊断。
Alzheimers Dement. 2020 Feb;16(2):283-291. doi: 10.1016/j.jalz.2019.08.189. Epub 2020 Jan 6.
7
Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis.体力活动和运动对阿尔茨海默病患者认知功能的影响:一项荟萃分析。
BMC Geriatr. 2019 Jul 2;19(1):181. doi: 10.1186/s12877-019-1175-2.
8
Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.较高的体重指数与认知正常的老年人较低的皮质淀粉样β蛋白负荷相关。
J Alzheimers Dis. 2019;69(3):817-827. doi: 10.3233/JAD-190154.
9
Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease.基于β淀粉样蛋白(Aβ)和tau蛋白结构的生物标志物,用于基于血液和脑脊液的两步招募策略,以识别阿尔茨海默病所致痴呆患者。
Alzheimers Dement (Amst). 2019 Mar 12;11:257-263. doi: 10.1016/j.dadm.2019.01.008. eCollection 2019 Dec.
10
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study.肥胖与阿尔茨海默病,肥胖悖论真的存在吗?一项磁共振成像研究。
Oncotarget. 2018 Oct 5;9(78):34691-34698. doi: 10.18632/oncotarget.26162.